About: Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 1995

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 1995 (uk) im März 1995 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 1995 (ast) scientific article published on 01 March 1995 (en)
publication date	wds:Q72532464-79F26392-C49E-4C70-83BA-1AACA7E413C4
publication date	1995-03-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q72532464-E0799A4D-4161-4FC2-AF2D-63B9A1942277
language of work or name	English
author name string	wds:Q72532464-20B073E2-F762-4F27-AA35-78F39FF81B9E wds:Q72532464-6A93389C-E3F2-490B-AC5B-D3A2C0455FFB wds:Q72532464-6BA2FB1B-DCC3-4F86-8E5F-EA867A4BEDA5 wds:Q72532464-84E26F77-6153-412E-9721-A20A071FB436 wds:Q72532464-CC0A3583-BAC0-4865-BBB6-2597122AF284 wds:Q72532464-EEC68768-97E1-44D3-B58F-EE90B5B7A589
author name string	J Høie G Saeter A E Stenwig O P Solheim E Hannisdal A K Johansson
rdfs:label	Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival (en) Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival (nl)
skos:prefLabel	Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival (en) Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival (nl)
name	Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival (en) Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival (nl)
title	wds:Q72532464-AF8DED75-9BD1-46B6-B12A-41FCF37D8FD0
title	Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival (en)
page(s)	wds:Q72532464-9BAACCA9-1C73-4597-9A8A-8B06B4795388
page(s)	1084-1093
instance of	wds:Q72532464-8AF963A2-76D4-44B7-AD84-0977AF37D076
instance of	scholarly article
PubMed ID	wds:Q72532464-BAAE2EBE-9F29-49DF-966D-D49A13780AA3
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7850705
PubMed ID	7850705
published in	wds:Q72532464-98C91EDC-DDC6-47A8-BF22-F6A08BBD5A9F
published in	Cancer
issue	wds:Q72532464-956C728A-9E16-45A0-AF72-AF3E8A9FFD49
volume	wds:Q72532464-788CB642-2C61-4DC1-B17E-D48B53BE2057
issue	5
volume	75
DOI	wds:Q72532464-2A18D7B5-2380-4EA0-B385-0D862C51A138
DOI	http://dx.doi.org/10.1002/1097-0142(19950301)75:5%3C1084::AID-CNCR2820750506%3E3.0.CO;2-F
DOI	10.1002/1097-0142(19950301)75:5<1084::AID-CNCR2820750506>3.0.CO;2-F
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72532464
is cites work of	Osteosarcoma Osteosarcoma in pediatric patients and young adults: a single institution retrospective review of presentation, therapy, and outcome Current strategies of chemotherapy in osteosarcoma Outcomes of Adolescent and Adult Patients with Lung Metastatic Osteosarcoma and Comparison of Synchronous and Metachronous Lung Metastatic Groups On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategy Comparison of pirarubicin-based versus gemcitabine-docetaxel chemotherapy for relapsed and refractory osteosarcoma: a single institution experience. Outcome after local recurrence of osteosarcoma: the St. Jude Children's Research Hospital experience (1970-2000) Therapy for osteosarcoma: where do we go from here? Historical, current and future aspects of osteosarcoma treatment Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders. Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy Pulmonary metastases in children with osteosarcoma: characteristics and impact on patient survival Prognostic factors for teenage and adult patients with high-grade osteosarcoma: an analysis of 240 patients Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma Osteosarcoma Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma: 63 patients with a minimum follow-up of 4 years High Dose Thiotepa in Patients with Relapsed or Refractory Osteosarcomas: Experience of the SFCE Group Survival of pediatric patients after relapsed osteosarcoma: the St. Jude Children's Research Hospital experience. Osteogenic sarcoma of the jaws: factors influencing prognosis Role of MRI in osteosarcoma for evaluation and prediction of chemotherapy response: correlation with histological necrosis Prognostic significance of 18F-FDG uptake in primary osteosarcoma after but not before chemotherapy: a possible association with autocrine motility factor/phosphoglucose isomerase expression Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience. Long-term pulmonary function after metastasectomy for childhood osteosarcoma: a report from the St Jude lifetime cohort study Prognostic factors and treatment results of high-grade osteosarcoma in norway: a scope beyond the "classical" patient. Genistein inhibits cell invasion and motility by inducing cell differentiation in murine osteosarcoma cell line LM8. Overexpression of cytoplasmic β-catenin inhibits the metastasis of the murine osteosarcoma cell line LM8. Osteosarcoma Overview The role of chemotherapy for metastatic, relapsed and refractory osteosarcoma Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward Treatment Outcomes in Children and Adolescents with Relapsed or Progressed Solid Tumors: a 20-year, Single-Center Study Reconstruction after resection of tumors around the knee: role of the free vascularized fibular graft. Recurrences following primary osteosarcoma in adolescents and adults previously treated with chemotherapy CD133 expression predicts lung metastasis and poor prognosis in osteosarcoma patients: A clinical and experimental study Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience. Evaluation of follow-up investigations in osteosarcoma patients: suggestions for an effective follow-up program Inhaled granulocyte-macrophage colony stimulating factor for first pulmonary recurrence of osteosarcoma: effects on disease-free survival and immunomodulation. a report from the Children's Oncology Group Identification of drug‐regulated genes in osteosarcoma cells All-trans retinoic acid and interferon-alpha in the treatment of a patient with resistant metastatic osteosarcoma. A Phase II Study of Docetaxel for the Treatment of Recurrent Osteosarcoma Role of PTEN and Akt in the regulation of growth and apoptosis in human osteoblastic cells A novel spontaneous metastasis model of human osteosarcoma developed using orthotopic transplantation of intact tumor tissue into tibia of nude mice Surgical treatment of pulmonary metastases in pediatric solid tumors. Chemotherapy in primary osteogenic sarcoma in patients over the age of forty A 20-year retrospective analysis of CT-based pre-operative identification of pulmonary metastases in patients with osteosarcoma: A single-center review. LAMP3 plays an oncogenic role in osteosarcoma cells partially by inhibiting TP53 Osteosarcoma: Diagnostic dilemmas in histopathology and prognostic factors Treatment of the patient with lung metastases Relation between cellular doxorubicin binding ability to nuclear DNA and histologic response to preoperative chemotherapy in patients with osteosarcoma. Osteosarcoma follow-up: chest X-ray or computed tomography? [Surgery of primary malignant bone tumors]

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software